Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd., commonly known as Hisun Pharma, is a major Chinese pharmaceutical company that specializes in the research, development, manufacturing, and distribution of pharmaceutical products. Founded in 1956, the company is headquartered in Taizhou, Zhejiang Province, China.

Hisun Pharma
has a diverse portfolio of products, including both generic and innovative medications. They cover a wide range of therapeutic areas, such as cardiovascular diseases, anti-infective drugs, oncology treatments, central nervous system medications, and more.

The company places a strong emphasis on research and innovation, investing significantly in drug development to bring new and effective treatments to patients. They collaborate with research institutions, universities, and other pharmaceutical companies to advance their pipeline of potential therapies.

Hisun Pharma
has a well-established manufacturing infrastructure and quality control systems to ensure the production of high-quality pharmaceutical products that meet international standards.

In addition to its pharmaceutical business, Hisun Pharma is also involved in the production and distribution of veterinary drugs, medical devices, and active pharmaceutical ingredients (APIs).

Hisun Pharma
has been expanding its global presence through international partnerships, collaborations, and exportation of its products to various countries and regions around the world.


Founded: 1956

Headquarters: Taizhou, Zhejiang Province, China

Website: https://www.hisunpharm.com/en/

Screenshot via https://www.cnhu.com/en
Screenshot via https://www.cnhu.com/en
Screenshot via https://www.cnhu.com/en
Screenshot via https://www.cnhu.com/en

Toplist Joint Stock Company
Address: 3rd floor, Viet Tower Building, No. 01 Thai Ha Street, Trung Liet Ward, Dong Da District, Hanoi City, Vietnam
Phone: +84369132468 - Tax code: 0108747679
Social network license number 370/GP-BTTTT issued by the Ministry of Information and Communications on September 9, 2019
Privacy Policy